Alexander V. Gordon

Alexander V. Gordon

Ask VT AI
View News Summary
  • Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
  • Jury selection faces challenges in the high-profile trial of Ryan Routh, who is accused of attempting to assassinate President Trump and is representing himself despite lacking legal training.
  • Michigan judge dismisses charges against 15 GOP fake electors, citing lack of criminal intent.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
  • Jury selection faces challenges in the high-profile trial of Ryan Routh, who is accused of attempting to assassinate President Trump and is representing himself despite lacking legal training.
  • Michigan judge dismisses charges against 15 GOP fake electors, citing lack of criminal intent.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Alexander V. Gordon